v3.26.1
Condensed Consolidated Statements of Changes in Stockholders’ Deficit - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional
Paid-In Capital
Accumulated
Deficit
Beginning balance (in shares) at Dec. 31, 2024   292,606    
Beginning balance at Dec. 31, 2024 $ (943,049) $ 3 $ 2,915,035 $ (3,858,087)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net (loss) income 576,251     576,251
Stock-based compensation 16,405   16,405  
Restricted stock awards issued (in shares)   2,981    
Restricted stock awards issued (50)   (50)  
Exercise of warrants (in shares)   3,500    
Exercise of warrants 41,625   41,625  
Ending balance (in shares) at Mar. 31, 2025   299,087    
Ending balance at Mar. 31, 2025 $ (308,818) $ 3 2,973,015 (3,281,836)
Beginning balance (in shares) at Dec. 31, 2025 314,231 314,231    
Beginning balance at Dec. 31, 2025 $ (962,740) $ 3 3,183,960 (4,146,703)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net (loss) income (347,188)     (347,188)
Stock-based compensation 18,387   18,387  
Restricted stock awards issued (in shares)   3,690    
Restricted stock awards issued 655   655  
Restricted stock awards withheld for tax withholding obligations (in shares)   (1,359)    
Restricted stock awards withheld for tax withholding obligations (21,651)   (21,651)  
Exercise of warrants (in shares)   387    
Exercise of warrants $ 6,851   6,851  
Ending balance (in shares) at Mar. 31, 2026 316,949 316,949    
Ending balance at Mar. 31, 2026 $ (1,305,686) $ 3 $ 3,188,202 $ (4,493,891)